<div id="readability-page-1"><div><p><span>Kumar Neil Chief Executive Officer of Bridgebio Pharma Inc [BBIO] filed a Form 4 on December 16, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:</span></p><div><table><tbody><tr><th><span>Date</span></th><th><span>Transaction</span></th><th><span>Shares</span></th><th><span>Price</span></th><th><span>Value</span></th></tr><tr><td><span>12/12/25</span></td><td><span>Exercise</span></td><td><span>60,975</span></td><td><span>$0.00</span></td><td><span>N/A</span></td></tr><tr><td><span>12/12/25</span></td><td><span>Surrender(1)</span></td><td><span>30,964</span></td><td><span>$75.15</span></td><td><span>$2,326,945</span></td></tr><tr><td><span>12/15/25</span></td><td><span>Planned Sale(2)</span></td><td><span>30,011</span></td><td><span>$74.64</span></td><td><span>$2,239,901</span></td></tr></tbody></table></div><p><span>Ending Holdings: 5,542,909 (228,776 - Direct, 5,314,133 - Indirect)</span></p><div><table><tbody><tr><td><span>(1)</span></td><td><span>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</span></td></tr><tr><td><span>(2)</span></td><td><span>Executed pursuant to a prearranged trading plan (10b5-1).</span></td></tr></tbody></table></div><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

BBIO

<p>Bridgebio Pharma Inc's CEO, Kumar Neil, sold 30,011 shares worth $2.2 million as part of a prearranged trading plan. The transaction was disclosed in a Form 4 filed with the SEC on December 16, 2025. Kumar's ending holdings are 5,542,909 shares, with 228,776 held directly and 5,314,133 indirectly.</p>

CEO Kumar Sells 30,011 ($2.2M) Of Bridgebio Pharma Inc [BBIO]